- Home
- TIGR vs PRAX Comparison
TIGR vs PRAX Comparison
Compare TIGR & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIGR
- PRAX
- Stock Information
- Founded
- TIGR 2014
- PRAX 2015
- Country
- TIGR China
- PRAX United States
- Employees
- TIGR N/A
- PRAX N/A
- Industry
- TIGR Investment Bankers/Brokers/Service
- PRAX Biotechnology: Pharmaceutical Preparations
- Sector
- TIGR Finance
- PRAX Health Care
- Exchange
- TIGR Nasdaq
- PRAX Nasdaq
- Market Cap
- TIGR 1.1B
- PRAX 1.2B
- IPO Year
- TIGR 2019
- PRAX 2020
- Fundamental
- Price
- TIGR $5.68
- PRAX $71.76
- Analyst Decision
- TIGR Hold
- PRAX Strong Buy
- Analyst Count
- TIGR 2
- PRAX 9
- Target Price
- TIGR $6.54
- PRAX $146.33
- AVG Volume (30 Days)
- TIGR 11.1M
- PRAX 317.5K
- Earning Date
- TIGR 11-12-2024
- PRAX 11-06-2024
- Dividend Yield
- TIGR N/A
- PRAX N/A
- EPS Growth
- TIGR N/A
- PRAX N/A
- EPS
- TIGR 0.19
- PRAX N/A
- Revenue
- TIGR $277,352,627.00
- PRAX $1,605,000.00
- Revenue This Year
- TIGR $62.80
- PRAX N/A
- Revenue Next Year
- TIGR $15.56
- PRAX N/A
- P/E Ratio
- TIGR $29.48
- PRAX N/A
- Revenue Growth
- TIGR 21.52
- PRAX N/A
- 52 Week Low
- TIGR $3.10
- PRAX $14.25
- 52 Week High
- TIGR $14.48
- PRAX $86.93
- Technical
- Relative Strength Index (RSI)
- TIGR 43.16
- PRAX 48.78
- Support Level
- TIGR $5.36
- PRAX $58.84
- Resistance Level
- TIGR $7.61
- PRAX $86.93
- Average True Range (ATR)
- TIGR 0.42
- PRAX 6.09
- MACD
- TIGR -0.16
- PRAX -0.15
- Stochastic Oscillator
- TIGR 14.22
- PRAX 46.00
About TIGR UP Fintech Holding Ltd representing fifteen
UP Fintech Holding Ltd is an online brokerage firm focusing on Chinese investors. Its trading platform enables investors to trade in equities and other financial instruments on multiple exchanges of stocks and other derivatives. The company offers its customers brokerage and value-added services, including trade order placement and execution, margin financing, account management, investor education, community discussion, and customer support.
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The firm's pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson's Disease; PRAX-562, and PRAX-222, among others.